NIH-funded research R01 grant

Finding genetic causes of unexplained childhood leukodystrophies with advanced long-read genome sequencing

Official title: Unraveling the Genomic Causes for Unsolved Leukodystrophy Patients by HiFi-GS

Funded at Children's Mercy Hosp (Kansas City, Mo) · NIH-11379779 · Data updated 2026-11-12

Using AI and more complete long-read genome sequencing to find hidden genetic causes in children with unexplained leukodystrophy.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionChildren's Mercy Hosp (Kansas City, Mo)
NIH-funded
Lab location1 site (Kansas City, United States)
Project startSeptember 20, 2024
Project endMay 31, 2029
Funding year2025
Award (this year)$107,722
NIH project number3R01HD111570-02S1
Project IDNIH-11379779 on NIH RePORTER

Who could benefit from this research

Could help

Children (approximately 0–11 years old) with leukodystrophy who remain without a genetic diagnosis after standard short-read genome sequencing are the ideal candidates.

Less likely to help

Children whose leukodystrophy already has a confirmed genetic diagnosis or whose condition is known to be non-genetic are unlikely to benefit directly from this project.

What this research studies

If your child joins, researchers will first use AI/ML tools to re-analyze existing short-read genome data and select about 125 children whose condition remains unsolved. Then they will apply long-read HiFi genome sequencing to those cases to search for hard-to-detect changes like repeat expansions, structural variants, methylation differences, and personal haplotype assemblies. The team will compare findings to a large pediatric reference dataset (GA4K) to help interpret rare or unusual variants. Results may help explain a child’s condition when previous tests were uninformative.

Why it matters

Potential benefit: This work could provide a genetic diagnosis for children who have had no clear explanation, which can end the diagnostic search and guide medical care and family planning.

How similar studies have gone: Earlier work using long-read HiFi genome sequencing has already found many variants missed by standard sequencing, so this approach builds on promising prior results.

Where this research is happening

  • Children's Mercy Hosp (Kansas City, Mo)
    Kansas City, United States
    Active

Researchers

  • Principal investigator: Pastinen, Tomi — Children's Mercy Hosp (Kansas City, Mo)
  • Study coordinator: Pastinen, Tomi

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.